Newsroom
Order our news
Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.
You can cancel this free service at any time by sending an e-mail to ir(at)freseniusmedicalcare.com, or by calling +49 (0) 6172 - 609 2525.
The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our privacy policy.
| Press release
Continued strong organic revenue growth across all regions; Record growth in home dialysis in North America; Improved earnings growth despite negative ESCO effect; Cost optimization initiatives on track; Outlook 2019 confirmed
| Short News
Spectra Laboratories broke ground on a 200,000-square-foot laboratory in Southaven, Mississippi yesterday. The project is expected to create more than 300 jobs over the next three years.
| Press release
| Press release
Underlying business development in line with expectations; Continued strong organic revenue growth; Healthy growth in the U.S. dialysis business
| Press release
Fresenius Medical Care is pleased the U.S. Administration’s plans for changing the way care is provided to people with kidney disease supports its existing strategy.
| Short News
Fresenius Medical Care North America (FMCNA) has announced an investment in BioIntelliSense, a Denver-based company that is developing a medical grade data services platform for continuous remote…
| Press release
